Trial intelligence / Profile preview

Metronidazole and Plaque Removal in Periodontitis

NCT00066001Phase 2Completed

Sponsor
ADA Forsyth Institute
Start
Dec 2002
Primary completion
Dec 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of metronidazole in periodontitis (4 arms), sponsored by ADA Forsyth Institute. Primary endpoint: Change in mean attachment level at 24 months. Started Dec 2002; status: completed.

02

Drugs

metronidazole
03

Conditions

periodontitis

Beyond the preview

Go deeper on NCT00066001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00066001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call